Alzamend Neuro Stock Probability of Future Stock Price Finishing Over 17.39
| ALZN Stock | USD 1.31 0.01 0.77% |
Alzamend |
Alzamend Neuro Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alzamend Neuro for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alzamend Neuro can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alzamend Neuro generated a negative expected return over the last 90 days | |
| Alzamend Neuro may become a speculative penny stock | |
| Alzamend Neuro has high historical volatility and very poor performance | |
| Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alzamend Neuro currently holds about 11.53 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Alzamend Neuro has a poor financial position based on the latest SEC disclosures |
Alzamend Neuro Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alzamend Stock often depends not only on the future outlook of the current and potential Alzamend Neuro's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alzamend Neuro's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 676.6 K | |
| Cash And Short Term Investments | 376 K |
Alzamend Neuro Technical Analysis
Alzamend Neuro's future price can be derived by breaking down and analyzing its technical indicators over time. Alzamend Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alzamend Neuro. In general, you should focus on analyzing Alzamend Stock price patterns and their correlations with different microeconomic environments and drivers.
Alzamend Neuro Predictive Forecast Models
Alzamend Neuro's time-series forecasting models is one of many Alzamend Neuro's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alzamend Neuro's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Alzamend Neuro
Checking the ongoing alerts about Alzamend Neuro for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alzamend Neuro help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alzamend Neuro generated a negative expected return over the last 90 days | |
| Alzamend Neuro may become a speculative penny stock | |
| Alzamend Neuro has high historical volatility and very poor performance | |
| Alzamend Neuro has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.95 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alzamend Neuro currently holds about 11.53 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Alzamend Neuro has a poor financial position based on the latest SEC disclosures |
Check out Alzamend Neuro Backtesting, Alzamend Neuro Valuation, Alzamend Neuro Correlation, Alzamend Neuro Hype Analysis, Alzamend Neuro Volatility, Alzamend Neuro History as well as Alzamend Neuro Performance. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.